Anti-VEGF therapy induces ECM remodeling and mechanical barriers to therapy in colorectal cancer liver metastasesNuh N. Rahbari, Dai Fukumura, Keehoon Jung et al.|Science Translational Medicine|2016Cited by 254
Targeting CXCR4-dependent immunosuppressive Ly6C <sup>low</sup> monocytes improves antiangiogenic therapy in colorectal cancerKeehoon Jung, Dai Fukumura, Takahiro Heishi et al.|Proceedings of the National Academy of Sciences|2017Cited by 135
Use of Angiotensin System Inhibitors Is Associated with Immune Activation and Longer Survival in Nonmetastatic Pancreatic Ductal AdenocarcinomaHao Liu, Kamila Naxerova, Matthias Pinter et al.|Clinical Cancer Research|2017Cited by 102
Dendritic cell paucity in mismatch repair–proficient colorectal cancer liver metastases limits immune checkpoint blockade efficacyWilliam W. Ho, Rakesh K. Jain, Igor L. Gomes‐Santos et al.|Proceedings of the National Academy of Sciences|2021Cited by 91